Myelin pathology: Involvement of molecular chaperones and the promise of chaperonotherapy

Federica Scalia, Antonella Marino Gammazza, Francesco Cappello, Antonella Marino Gammazza, Federica Scalia, Everly Conway De Macario, Francesco Cappello, Everly Conway De Macario, Alberto J. L. Macario, Alberto J.L. Macario

Risultato della ricerca: Articlepeer review

2 Citazioni (Scopus)


The process of axon myelination involves various proteins including molecular chaperones. Myelin alteration is a common feature in neurological diseases due to structural and functional abnormalities of one or more myelin proteins. Genetic proteinopathies may occur either in the presence of a normal chaperoning system, which is unable to assist the defective myelin protein in its folding and migration, or due to mutations in chaperone genes, leading to functional defects in assisting myelin maturation/migration. The latter are a subgroup of genetic chaperonopathies causing demyelination. In this brief review, we describe some paradigmatic examples pertaining to the chaperonins Hsp60 (HSPD1, or HSP60, or Cpn60) and CCT (chaperonin-containing TCP-1). Our aim is to make scientists and physicians aware of the possibility and advantages of classifying patients depending on the presence or absence of a chaperonopathy. In turn, this subclassification will allow the development of novel therapeutic strategies (chaperonotherapy) by using molecular chaperones as agents or targets for treatment.
Lingua originaleEnglish
pagine (da-a)297-
Numero di pagine11
RivistaBrain Sciences
Stato di pubblicazionePublished - 2019

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2800.2800???


Entra nei temi di ricerca di 'Myelin pathology: Involvement of molecular chaperones and the promise of chaperonotherapy'. Insieme formano una fingerprint unica.

Cita questo